Galectin-3 as a Predictor of Left Ventricular Reverse Remodeling in Recent-Onset Dilated Cardiomyopathy

OBJECTIVES: Studies have evaluated the association of galectin-3 and outcome in patients with heart failure. However, there is still scarce evidence concerning the clinical usefulness and predictive value of galectin-3 for left ventricular reverse remodeling (LVRR) in patients with recent-onset dila...

Descripción completa

Detalles Bibliográficos
Autores principales: Karatolios, Konstantinos, Chatzis, Georgios, Holzendorf, Volker, Störk, Stefan, Richter, Anette, Binas, Davis, Schieffer, Bernhard, Pankuweit, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029471/
https://www.ncbi.nlm.nih.gov/pubmed/30018673
http://dx.doi.org/10.1155/2018/2958219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029471/
https://www.ncbi.nlm.nih.gov/pubmed/30018673
http://dx.doi.org/10.1155/2018/2958219

Ejemplares similares